A TrkB antibody agonist promotes plasticity following cervical spinal cord injury in adult rats.
Following spinal cord injury (SCI) in mammals, there is only limited repair and consequently only moderate recovery. One mechanism frequently discussed to be involved in this recovery is plasticity, i.e., adaptations in spared neuronal circuitries. In the current study we tested the effect of an intrathecal application of the TrkB agonist antibody 29D7 on plasticity following cervical SCI in adult rats. Treatment with 29D7 for 4 weeks resulted in ~50 % increase in collateral sprouting of severed corticospinal tract fibers above the lesion compared to the control group, and enhanced branching in the grey matter rostral to the injury. GAP-43 immunoreactivity in the spinal cord rostral to the level of the injury as well as contralateral to the lesion was also increased. These indications of enhanced plasticity by 29D7 were paralleled by improved performances of the mildly affected paw, as assessed by Montoya and tray reaching tasks. The reaching behaviors of the paw ipsilateral to the side of severe injury to the cortico- and rubro-spinal tract were not altered by the treatment. The present study suggest that 29D7 may be a potential candidate to promote plasticity and functional recovery, especially following moderate SCI. Future studies confirming these results, along with a potential combinatory therapy including rehabilitative training, will be needed to evaluate the clinical value of such a treatment.